By Dr. Chinta SidharthanDec 6 2023Reviewed by Lily Ramsey, LLM In a recent study published in the journal Npj Parkinson’s Disease, researchers meta-analyzed data obtained from a systematic review to understand the risk factors that influence the development of freezing of gait or FOG — a debilitating condition that occurs in some Parkinson’s disease patients....
Tag: <span>Parkinson disease</span>
Post
Dopamine agonists and dopamine reuptake inhibitors provide similar quality of life for Parkinson disease patients
For patients with Parkinson disease on levodopa therapy, patient-rated quality of life is similar for those receiving adjuvant therapy with dopamine agonists compared with dopamine reuptake inhibitors (DRIs); and among DRIs, monoamine oxidase type B (MAO-B) inhibitors are preferable to catechol-O-methyltransferase (COMT) inhibitors, according to a study published online Dec. 28 in JAMA Neurology. Richard Gray,...